David Beeson Weatherall Institute of Molecular Medicine Oxford Pathogenic mechanisms underlying...

transcript

David BeesonWeatherall Institute of Molecular Medicine

Oxford

Pathogenic mechanisms underlying synaptic dysfunction

in congenital myasthenic syndromes

Endplate region

Congenital myasthenic syndromes

• Genetic

• Fatiguable muscle weakness

• Heterogeneous

Clustered AChRAgrin

MuSKRapsyn

CMS-associated genes

CHRNACHRNBCHRNDCHRNECHRNG

RAPSNMUSKDOK-7

Congenital myasthenic syndromes

Syndrome Kinships

AChR deficiency CHRNE 112

AChR deficiency – (RAPSN) 51

CMS with proximal weakness (DOK7) 55

Slow channel (CHRNA/B/D/E) 22

Fast channel (CHRNA/D/E) 12

AChE deficiency (COLQ) 15

Presynaptic (CHAT) 8

Additional referrals no mutations found

(Studied in Oxford)

Neuromuscular synapse(a complex structure)

Clustered AChR

MuSKRapsyn

Postsynaptic specialisation

Clinical features of Dok-7 CMS

Inheritance - recessive

Onset - 1.5 – 4 years, sometimes respiratory problems at birth

Symptoms - limb girdle pattern of weakness, ptosis, but eye muscles unaffected

Responsive - ephedrine salbutamol

Unresponsive - pyridostigmine

C-terminalPH PTB

1263insC

1339_1342dupCTGG

1143insC

548_551delTCCT

1124_1127dupTGCC

601C>T 1508insC

1378insC

1357_1370del14

Dok-7 mutations

Common mutation

IVS1+14del15

IVS2-1G>T

1504_1505insTA437delC

481G>A

539G>C

496G>A

596delT

230C>T

473G>A

1185C>G

415G>C967C>T

101_141del 1487G>T

325G>T

Differentiate

+ Agrin

Myoblasts

Transfect with mutant cDNA

Myotubes AChR

AChR clusters

In vitro clustering assay

C2C12RAPSN -/-

MUSK -/-

Myotubes

Dok-7 induced AChR clusters in C2C12 cellsMyotubes – no Dok-7

Dok-7 mutant

Dok-7 WT

(Fewer and smaller clusters)

elTCCT

1143insC

AChR clusters in C2C12 myotubesinduced by truncated Dok-7

Type of AChR clusters formed following expression of Dok-7 in C2C12 cells

BranchedC-shapedPerforated Endplate

c-shaped and perforated

pBABEW

0123456789

Average length of AChR Clusters

1277in

er len

Number of clusters

** * * *

* * * *

1 way ANOVA Bonferroni’s multiple comparison

1 way ANOVA Tukey's Multiple Comparison Test

branched

pBABEW

all significant

AChR clusters in cultured human myotubes

Agrin-induced clusters on myotubes derived from a Dok-7 patient

Can patients with DOK7 mutations be treated?

• Unresponsive to cholinesterase medication

• Some show some benefit fro 3,4-DAP

• Remarkable response to ephedrine salbutamol

Wheelchair/scoliosis to running and jumping

Wheelchair to running 200 metres

Legs raised

Arms raised

Time on treatmentT

Baseline 1st dose 2 months 6-8 months0

Time on treatment

Disability score

GDok-7 CMS patients respond to

treatment with ephedrine

Effect of ephedrine on AChR clusters in human myotubes from a Dok-7 patient

homozygous for 1124_1127dupTGCC

400 Clusters per fieldCluster length

- -+ +Ephedrine Ephedrine

40% 3.4-foldincrease increase

Truncated Dok-7

Clustered AChRAgrin

Rapsyn

Impaired kinase signalling

Retrograde signalling

reduced MuSK-P*

C-terminal domainPH PTB

1124_1127dupTGCCPTB motif NPXY

Ephedrine

Maintaining synaptic structure

Dr Palace + CliniciansYuji YamanashiAngela Vincent + team

Collaborators:

Extracellular ring

Intermediate ringCytoplasmic ring

Conductance of ion channel largely governed by three rings of charged amino acids

Fetal Adult

• Larger conductance

• Shorter openings

Imoto et al.

Case Study

• Clinical features:

– 47 yr woman

– Onset at birth: generalised weakness and ptosis

– Progressive course:Fatigable limb weakness

Severely restricted eye movements

Responsive to pyridostigmine (high dose)

– Respiratory arrest aged 45, hypoxic brain injury

DNA screening revealed two mutations

• Epsilon subunit– P282R missense– F266 in frame deletion

Surface expression

•Cell-attached patch recordings

•Transfected HEK 293 cells

•Constant low concentration of acetylcholine

Electrophysiological methodology

Closed

Log10 duration (ms)

Burst length

Hundreds/thousands of bursts are measured

1: 0.11+/- 0.032: 1.19 +/- 0.223: 4.68 +/- 0.74

Wildtype AChR recordings

Size of F266 opening are reduced

Pipette potential

Slope conductance reduced

Wildtype AChR

F266 AChR

Ohm’s Law:

V = I ×R

R = V ÷ I

Conductance= 1/R

Excess Na+,Ca 2+ Insufficient Na+

PROLONGEDACTIVATION

SHORTENED ACTIVATION

REDUCEDCONDUCTANCE

Insufficient Na+

Kinetic abnormalities of the AChR

Figure 3: Time (seconds) for individual patients in A: Arms raised 90 degrees and B: Legs raised 45 degrees (data points are mean of right side and left side scores).

• 47 year old female with symptoms weakness since birth

• Progrssive bulbar, repiratory and limb muscle involvement

• Positive response to pyridostigmine, but no improvement with 3,4-DAP

• At 45 suffered respiratory arrest with resultant hypoxic brain damage

• No family history

Novel AChR abnormality

Heteroallelic for mutations in CHRNE ( subunit)

Agrin-induced clusters on myotubes derived from a Dok-7 patient

Normal Mutant

AChR deficiency

Inverted screen test

Myotubes – no Dok-7

Dok-7 common mutation

Dok-7 WT

Dok-7 induced AChR clusters

Comparison of AChR deficiency phenotypes with early onset

presentationClinical feature Early Onset

rapsyn mutations

AChR deficiency -subunit mutations

Arthrogryposis Common Absent

Episodic crises Common Rare

Ophthalmoplegia

Absent Common

Spontaneous improvement

Common Rare

Clustered AChRAgrin

MuSKRapsyn

CMS-associated genes

CHRNACHRNBCHRNDCHRNECHRNG

RAPSNMUSKDOK-7

Mild arthrogryposis

RAPSN mutation

Muscle AChR

Adult Fetal

Transgenic slow channel mouse with AChR-EGFP

NFP /synaptophysinL221F-EGFP merge

S low channel

Normal S low channel

S low channelS low channel

Normal S low channel

Dok-7 induced AChR clusters in C2C12 cellsMyotubes – no Dok-7

Dok-7 mutant

Dok-7 WT

David Beeson Weatherall Institute of Molecular Medicine Oxford Pathogenic mechanisms underlying...

Documents